High performance liquid chromatographic determination of some co-administered anticancer drugs in pharmaceutical preparations and in spiked human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 34, Issue 5, 2004, Pages 1099-1107

  Fahmy, Ossama T ^a   Korany, Mohamed A ^a   Maher, Hadir M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

5 Fluorouracil; Co administered anticancer drugs; Cytarabine; Determination; Doxorubicin; Etoposide; HPLC; Plasma

Indexed keywords

ACETONITRILE; ANTINEOPLASTIC AGENT; BENZOIC ACID DERIVATIVE; BENZYL ALCOHOL; CYTARABINE; DISODIUM HYDROGEN PHOSPHATE; DODECYL SULFATE SODIUM; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHYL HYDROXYBENZOATE; PHOSPHORIC ACID; SODIUM HYDROXIDE; UNCLASSIFIED DRUG;

ACCURACY; ACIDITY; ANALYTICAL EQUIPMENT; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; ENVIRONMENTAL TEMPERATURE; FLOW RATE; HUMAN; PHASE SEPARATION; POWDER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

ACETONITRILES; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; HUMANS; HYDROGEN-ION CONCENTRATION; PHARMACEUTICAL PREPARATIONS;

EID: 1542332482     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(03)00655-1     Document Type: Article

References (19)

1. British Pharmacopoeia, HMSO, London, 2001.
2. United States Pharmacopoeia 24, The National Formulary 19, US Parmacopoeial Convention Inc., Rockville, MD, 2000.
3. Chen C.L., Thoen K.K., Uckun F.M. J. Chromatogr. B: Biomed. Appl. 764:2001;81-119.
4. Loadman P.M., Calabrese C.R. J. Chromatogr. B: Biomed. Appl. 764:2001;193-206.
5. Zagotto G., Gatto B., Moro S., Sissi C., Palumbo M. J. Chromatogr. B: Biomed. Appl. 764:2001;161-171.
6. Krishnaiah Y.S.R., Karthikeyan R.S., Satyanarayana V. Indian Drugs. 39:2002;23-26.
7. Liu C.H., Liu S.L., Bian J.F., Geng Z., Lu Y., Hu H.Y. Yaowu Fenxi Zazhi. 21:2001;95-97.
8. Escoriaza J., Aldaz A., Calvo E., Giraldez J. J. Chromatogr. B: Biomed. Appl. 736:1999;97-102.
9. Micoli G., Turci R., Arpellini M., Minoia C. J. Chromatogr. B: Biomed. Appl. 750:2001;25-32.
10. Kissinger L.D., Stemm N.L. J. Chromatogr. 26:1986;353309-353318.
11. Galushko S.V., Shishkina I.P. J. Pharm. Biomed. Anal. 10:1992;1093-1095.
12. Arbuck S.G., Silk Y., Douglass H.O. Jr., Nava H., Rustum Y.M., Milliron S. Cancer. 65:1990;2442-2445.
13. Volm M., Mattern J. Anticancer Res. 12:1992;2293-2296.
14. Dimery I.W., Legha S.S., Shirinian M., Hong W.K. J. Clin. Oncol. 8:1990;1056-1062.
15. Paik S., Bryant J., Tan Chiu E., Yothers G., Park C., Wickerham D.L., Wolmark N. J. Natl. Cancer Inst. 92:2000;1991-1998.
16. Ritzi E.M., Pyo S. Life Sci. 54:1994;887-900.
17. Lee J.H., Lee K.H., Kim S., Seol M., Kim S.H., Kim W.K., Lee J.S. Leukemia Res. 25:2001;305-312.
18. Gisselbrecht C., Oksenhendler E., Tirelli U., Lepage E., Gabarre J., Farcet J.P., Gastaldi R., Coiffier B., Thyss A.et al. Am. J. Med. 95:1993;188-196.
19. Physician's Desk Reference Electronic Library, ver. 6.0.0a, 57th ed., Medical Electronics, 2003.